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ABSTRACT  
Background
Heart failure (HF) is common in long-term care (LTC). 
Diagnostic uncertainty is important barrier to optimal HF 
management, stemming from inadequate health information 
transfer upon LTC admission. We determine the utility of 
admission clinical information to confirm a HF diagnosis in 
new LTC residents.
Methods
This was a prospective cohort study. From February 2004 to 
November 2006, information about new residents from 41 
LTC homes in Ontario, Canada, was collected from residents 
and caregivers, and all available health records. A prior HF 
diagnosis was confirmed by consensus review of available 
data by two independent experts. Multivariate modelling 
was utilized to determine the utility of the admission clinical 
assessment in confirming a prior HF diagnosis.
Results
A total of 449 residents were included for analysis, aged 
84.3±6.5 years, and 21.6% had a prior HF diagnosis. The 
most useful clinical item for diagnosing HF was a “history 
of HF”. The final model included “history of HF’ (OR  [odds 
ratio] 13.66, 95% CI 6.61–28.24), “fluid on the lungs” (OR 
2.01, 95% CI 1.04–3.89), “orthopnea” (OR 1.76, 95% CI 
0.93–3.33), “taking β-blocker” (OR 2.09, 95% CI 1.10–
3.94), “taking loop diuretics” (OR 2.11, 95% CI 1.12–3.98), 
and “history of coronary artery disease” (OR 2.83, 95% CI 
1.42–5.64).
Conclusion
Elements of the clinical assessment for new LTC residents 
can help confirm a prior HF diagnosis. An admission history 
of HF is highly predictive.
Key words: heart failure, elderly, nursing home, long-term 
care, diagnosis, transition
INTRODUCTION
Heart failure (HF) predominantly affects seniors, many 
of whom are frail and disabled.(1-4) According to a recent 
systematic review, the prevalence of HF in long-term care 
(LTC) homes, which provide 24-hour nursing care to frail 
persons no longer able to reside in the community, reaches 
20%.(5,6) The one-year mortality of HF in LTC reaches 40%, 
a rate 50% higher than among residents without HF.(7-9) HF 
accounts for approximately 20% of transfers of LTC residents 
to hospital, and it is considered that many admissions and 
resulting complications could be prevented with better HF 
management in LTC.(7,10-16)
Older persons with HF are less likely to be prescribed 
recommended HF therapies, despite evidence that these can 
be beneficial even among frail seniors.(17,18) An important 
barrier to appropriate prescribing of HF medications to frail 
seniors is diagnostic uncertainty.(19,20)  The diagnosis, treat-
ment, and prognosis of HF in older adults is often complicated 
by geriatric syndromes including frailty and psychogeriatric 
disorders.(17,19)  Frail older HF patients, particularly those 
with difficulty completing activities of daily living, often 
manifest atypical signs and symptoms, leading to diagnostic 
delays, inappropriate prescribing, functional decline, and 
increased health care utilization.(19,21) Frail persons may have 
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difficulty providing accurate information to health providers.
(22) Furthermore, when an older person is admitted to LTC, 
the transfer of health information from sending organiza-
tions is often inadequate.(22)  Such poor transitions have been 
associated with suboptimal care and an increased risk of 
hospitalization and complications.(23) Ensuring the adequacy 
of diagnostic information upon LTC admission is crucial for 
optimal HF management.
The objective of this paper is to determine the utility of 
the admission clinical assessment for LTC residents in con-
firming a prior HF diagnosis. 
METHODS
The Geriatric Outcomes and Longitudinal Decline in Heart 
Failure (GOLD-HF) study took place in South-Central On-
tario from February 2004 to November 2006, and included 
Hamilton (25 LTC homes), Cambridge (seven homes), and 
Kitchener-Waterloo (nine homes). The GOLD-HF study was 
a prospective longitudinal study designed to compare over a 
one-year period the clinical course of newly admitted LTC 
residents with HF to those without HF. This study complies 
with the Declaration of Helsinki, was approved by the Re-
search Ethics Board of McMaster University, and informed 
consent was obtained from all subjects or guardians.
Participants
Newly admitted and consecutive LTC residents aged 65 years 
or over were considered for inclusion. Excluded were resi-
dents with advanced malignant or non-malignant illness and 
expected to die within 6 weeks; those admitted from another 
LTC home (unless they had been residing there less than 6 
weeks); those admitted to LTC for temporary respite to pri-
mary caregivers and expected to return to the community; and 
those for whom informed consent could not be obtained. Staff 
at participating homes sought permission from new residents 
or substitute decision-makers for referral to study nurses, who 
were then allowed to formally approach potential participants 
for consent. The period of 6 weeks for inclusion into the study 
was required by LTC homes to complete routine admission 
procedures prior to resident recruitment.
Data Collection
Baseline Assessment
A trained research nurse assessed all participants and reviewed 
the LTC home chart. For patients with communication dif-
ficulties or cognitive impairment, history was obtained from 
family caregivers. Baseline information collection included 
demographic data and medical history, HF signs and symp-
toms, and the most recent diagnostic investigations. Medical 
history information included the following disease diagnoses: 
pulmonary disease, coronary artery disease, valvular heart 
disease, hypertension, atrial fibrillation, hyperlipidemia, 
peripheral vascular disease (PVD), cerebrovascular events, 
diabetes mellitus, dementia, arthritis, osteoporosis and/or 
fragility fractures, cancer, renal insufficiency, and mood 
disorders. Prior smoking exposure and baseline function 
and cognition were also recorded. Prescribed medications 
were recorded and a medication count of regularly taken 
medications was created. Specific note was made of baseline 
use of angiotensin converting enzyme inhibitors (ACEi), an-
giotensin receptor blockers (ARB), beta-adrenergic receptor 
blockers (β-blockers), spironolactone, digoxin, loop diuret-
ics, anti-platelets, anticoagulants, calcium channel blockers, 
antidepressants, and major and minor tranquilizers. Residents 
underwent a targeted physical examination. Assessment of 
functional, cognitive, and neuropsychiatric status, based on 
a review of the LTC chart and interview with the resident’s 
primary caregiver or nurse, was performed using the Barthel 
Index (BI),(24) the Minimum Data Set Cognitive Scale,(25) the 
Cohen-Mansfield Agitation Inventory,(26) and Neuropsychi-
atric Inventory.(27)
Ascertaining a Prior Heart Failure Diagnosis 
In order to ascertain a prior HF diagnosis, the research nurse 
obtained consent from participants (or substitute decision-
makers) to search for medical records from previous physi-
cians, hospitalizations, and diagnostic procedures, information 
generally not readily available to admitting LTC homes.(16,22) 
All data thus gathered were reviewed independently by two 
experts (GAH, RSM), who categorized the diagnosis of HF 
as true, possible, nor not present; disagreements resolved 
through discussion. Of 546 resident charts reviewed, there 
were 75 cases in which reviewers disagreed and 12 cases 
in which both reviewers were initially uncertain (Weighted 
Kappa = 0.73); all cases were resolved by discussion. The 
diagnosis of HF was based on accepted diagnostic criteria.
(18,28) The presence of other diagnoses was also verified from 
review of this information.
Statistical Considerations
Baseline characteristics were summarized using mean and 
standard deviation for continuous measures, frequency, and 
percentage for categorical measures, and compared using 
t-test and Chi-square test, respectively. Unconditional es-
timates of sensitivity, specificity, positive predictive value, 
negative predictive value, and c-statistic were calculated for 
an admission “history of HF”, “history of fluid on the lungs”, 
symptoms and signs of HF, baseline physical findings, and 
calculated creatinine clearance.(29) Other indicators consid-
ered were co-morbidities, including hypertension, coronary 
artery disease (CAD), diabetes mellitus, atrial fibrillation, 
and renal insufficiency (defined as a calculated creatinine 
clearance < 60 mls/min), and use of HF medications (loop 
diuretics, ACEi, β-blockers, and digoxin).  Multiple logistic 
regression was used to identify the strongest predictors of a 
prior HF diagnosis. Multi-collinearity was considered and 
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determined not to be significant, with estimates of the Pear-
son correlation less than 0.7 and variance inflation factors 
less than 2.5. Stepwise elimination was used to develop the 
final model, with remaining variables significant at the 5% 
level. Model fit was assessed using the likelihood ratio test, 
comparing the full and reduced models, and was found not 
to be significant. The integrated discriminant improvement 
(IDI) index was determined by sequentially adding variables 
in order of most to least informative c-statistic using the SAS 
ROCPLUS macro.(30,31) Variables were included in the final 
model if inclusion resulted in significant improvement at the 
5% level. All analyses were conducted in SAS version 9.1 
(SAS Institute Inc., Cary, NC).
RESULTS 
The study enrolled 546 residents, and analysis will focus on 
449 residents for whom creatinine clearance could be esti-
mated. Mean age was 84.3±6.5 years and 66% were women, 
and a prior HF diagnosis was confirmed in 97 (21.6%) resi-
dents. Table 1 presents baseline characteristics of the sample. 
Almost half were admitted from hospital, with HF patients 
more likely to have been so. Participants had multiple medical 
co-morbidities, were prescribed multiple medications, and had 
significant functional and cognitive deficits. Residents with 
prior HF were older, more likely to have hypertension, CAD 
and atrial fibrillation, and had more acute care visits prior to 
LTC admission, than those with no prior HF. Results of an 
echocardiogram were available for 69 (71%) of residents with 
prior HF, 67% of whom had a left ventricular ejection fraction 
greater than 40% (preserved ejection fraction).
Table 2 presents data from the admission clinical assess-
ment. A “history of HF” and symptoms and signs of HF were 
more common in patients with prior HF. However, some were 
also common in residents without HF, such as peripheral ede-
ma, which was reported by almost 60% of residents without 
HF. Among residents without prior HF, 17.9% claimed such 
a history. There were no statistically significant differences 
in the prevalence of physical findings of peripheral edema 
and auscultatory rales between both groups. Jugular venous 
pressures (JVP) were generally in the normal range and third 
heart sounds infrequent, suggesting that most residents are 
clinically stable following LTC admission.
Table 3 presents diagnostic properties of elements from 
the admission clinical assessment pertinent to HF. The most 
useful item is “history of HF”. Elements pertaining to dys-
pnea have more modest sensitivities and specificities; speci-
ficity generally rises while sensitivity falls with increasing 
dyspnea severity. Orthopnea and paroxysmal nocturnal dys-
pnea (PND) were relatively specific, though not very sensi-
tive. In contrast, “history of peripheral edema” was sensitive, 
but non-specific. There are notable differences between the 
properties of elements derived from the LTC chart and those 
obtained from the resident/caregiver interview. For histories 
of peripheral edema and varying degrees of dyspnea, the 
sensitivity of chart-derived information is uniformly lower, 
and the specificity higher, than that of interview-derived 
information. However, differences are less marked for ele-
ments suggestive of severe HF, such as PND, orthopnea, or 
dyspnea at rest or when performing basic activities of daily 
living. With respect to physical findings, both auscultatory 
rales and peripheral edema had poor sensitivity and positive 
predictive value, and modest specificity and negative predic-
tive values. The utility of the JVP and auscultion for a third 
heart sound was limited in this sample. Table 4 presents the 
utility of cardiovascular co-morbidities and admission medi-
cations with respect to a prior HF diagnosis. The absence of 
cardiovascular morbidities was associated with good to very 
good negative predictive values, particularly a history of 
CAD. The sensitivity and specificity of individual prescribed 
medications were modest, other than for digoxin, which ap-
pears to be specific for a prior HF diagnosis. 
Logistic regression models were derived to determine 
which combination of elements from the admission assess-
ment was most predictive of a prior HF diagnosis. Results 
are shown in Table 4. The final model includes histories of 
“HF”, “fluid on the lungs”, orthopnea, CAD, and the use of 
β-blockers and furosemide. The c-statistic was 0.910; the IDI 
method arrived at the same final model.
DISCUSSION
This study confirms the high prevalence of HF in LTC and 
the complexity of residents with this condition. Ensuring an 
accurate HF diagnosis during the transition of residents into 
LTC is crucial for optimal management of this condition. 
This study provides important information on the value of 
the admission assessment of new LTC residents in confirming 
a prior HF diagnosis. Our findings are consistent with other 
literature showing that features of HF can be non-specific 
in frail seniors.(19,21,32) For example, dyspnea, a cardinal 
symptom of HF, is only reported for 38.5% to 62.4% residents 
with prior HF.
We observed differences in the sensitivity and specific-
ity of elements of the admission assessment depending on 
whether information was obtained from the resident chart or 
from resident/caregiver interview. Direct history was more 
sensitive but less specific than chart information for peripheral 
edema, orthopnea, and dyspnea, though differences were less 
marked for more severe symptoms such as resting dyspnea. 
These suggest discrepancy in the importance ascribed to HF 
symptoms by residents and by LTC staff recording observa-
tions in resident charts. Symptoms are experienced subjectively 
by patients, and thus LTC staff charting may be inherently 
sensitive to symptom identification than resident reporting. 
These data are consistent with a recently reported communi-
cation gap(33) between LTC staff and residents, either leading 
to under-reporting of mild symptoms by residents, or to staff 
erroneously dismissing milder symptoms as “normal aging”. 
These data reinforce the critical importance of a thorough 
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history, including collection of collateral information, in order 
to accurately assess frail seniors with HF.(19)
That a “history of HF” is predictive of a prior HF diag-
nosis may seem self-evident, but it is an important finding 
given the uncertainty surrounding the accuracy of health 
information available to clinicians about new LTC residents. 
There are a number of explanations for this finding. Older 
persons with HF are often hospitalized repeatedly, experi-
ence functional decline, and ultimately discharged to LTC.
(34-36) In our study, almost 60% of participants were admitted 
from acute care. It is therefore likely that because most new 
LTC residents with HF had a recent hospitalization, available 
clinical information was more reliable. Furthermore, all LTC 
residents  in Ontario undergo standardized assessment using 
the RAI (Home Care) instrument prior to admission.(37) The 
RAI family of instruments have been shown to have a high 
positive predictive value for HF.(38)
Our data suggests that the idiom “fluid on the lungs” may 
be useful to explain HF to lay persons (www.heartfailure.org/
eng_site/hf_lungs.asp). While the low sensitivity implies that 
the idiom is not universally used, the high specificity suggests 
that it is an effective descriptor. Specifically, using this idiom 
when interviewing a LTC resident/caregiver improves the 
predictive value of the assessment.
TABLE 1.
Baseline characteristics of LTC residents
Characteristic No prior HF 
N = 352 (%)
Prior HF 
N = 97 (%)
p value
 Age (in years) 83.8±6.5 85.9± 6.3 0.0048
Male 115 (32.7) 36 (37.1) 0.4122
Admitted from
Hospital
Home
Retirement home/senior’s residence
160 (45.5)
130 (36.9)
62 (17.6)
58 (59.8)
28 (28.9)
11 (11.3)
0.0394
No. of hospitalizations or ED visits in year prior to admission to LTC 1.3±1.2 1.9±1.5 0.0014
Cardiovascular history
Hypertension
Diabetes mellitus
Hyperlipidemia
CAD
PVD
CVD
Atrial fibrillation
Echocardiogram available
LVEF > 50%
LVEF 40%–50%
LVEF 25%–40%
LVEF <25%
252 (71.6)
87 (24.7)
132 (37.5)
142 (40.5)
46 (13.1)
165 (46.9)
81 (23.0)
109 (31.0)
100 (91.7)
8 (7.3)
1 (0.9)
0
83 (85.6)
28 (28.9)
43 (44.3)
79 (81.4)
18 (18.6)
50 (51.5)
55 (56.7)
69 (71.1)
29 (29.9)
17 (17.5)
14 (14.4)
5 (5.2)
0.0051
0. 4070
0.2220
<0.0001
0.1744
0.4148
<0.0001
<0.0001 
Co-morbidities
Pulmonary disease
Renal insufficiencya
Venous thromboembolic disease
Mood disorder
Anxiety disorder
Dementia
Parkinson’s disease or related disorder
Arthritis
Osteoporosis or fragility fracture
History of cancer
126 (35.9)
47 (13.4) 
27 (7.7)
141 (40.1)
73 (20.7)
236 (67.0)
39 (11.1)
235 (66.8)
199 (56.5)
77 (21.9)
49 (51.0)
37 (38.1)
15 (15.6)
33 (34.0)
22 (12.7)
48 (49.5)
6 (6.2)
73 (75.3)
49 (50.5)
27 (27.8)
0.0071
<0.0001
0.0182
0.2799
0.6784
0.0015
0.1553
0.1104
0.2912
0.2180
Functional and neuropsychiatric measures
MDS-Cog
Barthel Index
Cohen Mansfield Agitation Inventory
Neuropsychiatric Inventory
3.6±2.6
10.9±5.4
37.1±2.5
7.5±11.7
2.9±2.6
10.7±5.3
33.6±9.8
5.5±9.9
0.0235
0.7796
0.0040
0.1238
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TABLE 1.
Continued
Characteristic No prior HF 
N = 352 (%)
Prior HF 
N = 97 (%)
p value
Pharmacotherapy
Total number of regularly scheduled medications
Angiotensin Converting Enzyme inhibitor
Angiotensin receptor blocker
β-blocker
Digoxin
Furosemide
Spironolactone
Nitrates
Calcium channel blocker
Vasodilators
Antiplatelet agent
Warfarin
Lipid-lowering agentb
7.5±3.4
110 (31.3)
23 (6.5)
79 (22.4)
24 (6.8)
83 (23.6)
16 (4.5)
72 (20.5)
75 (21.3)
2 (0.6)
161 (45.7)
46 (13.1)
86 (24.4)
9.5±3.3
45 (46.4)
14 (14.4)
46 (47.4)
24 (24.7)
64 (66.0)
13 (13.4)
52 (53.6)
21 (21.6)
3 (3.1)
56 (57.7)
36 (37.1)
32 (33.0)
<0.0001
0.0055
0.0122
<0.0001
<0.0001
<0.0001
0.0017
<0.0001
0.9419
0.0669
0.0364
<0.0001
0.0900
a  Renal insufficiency is define as a calculated creatinine clearance < 60 mls/min, according to the Cockcroft-Gault equation.
b  All residents on lipid lowering agents were receiving HMG-CoA reductase inhibitors, and one resident was also receiving treatment with 
a fibrate.
hf = heart failure; ltc = long-term care; ed = emergency department; cad = coronary artery disease (history of myocardial infarction, angina/
unstable angina, or history of coronary revascularization); pvd = peripheral vascular disease (history of intermittent claudication, revascu-
larization, or abdominal aortic aneurysm); cvd = cerebrovascular disease (history of transient ischemic attack, stroke, or revascularization 
procedure); lvef = left ventricular ejection fraction 
TABLE 2.
Heart failure history, symptoms, and signs elicited at the baseline assessment either from  
the resident/caregiver interview or from the LTC home chart review
Element of the LTC Admission Clinical Assessment No HF
(N=352)
HF
(N=97)
p value
History of
Heart failure 63 (17.9%) 85 (87.6%) <0.0001
Fluid on the lungs 37 (10.5%) 49 (50.5%) <0.0001
Peripheral edema 209 (59.4%) 82 (84.5%) <0.0001
Orthopnea 63 (17.9%) 44 (45.4%) <0.0001
Paroxysmal nocturnal dyspnea 34 (9.7%) 30 (30.9%) <0.0001
Dyspnea on moderate activity 123 (35.0%) 59 (60.8%) <0.0001
Dyspnea compared to peers 54 (15.4%) 37 (38.1%) <0.0001
Dyspnea walking on a level surface 91 (25.9%) 59 (60.8%) <0.0001
Dyspnea with activities of daily living 56 (16.0%) 49 (50.5%) <0.0001
Dyspnea at rest 36 (10.3%) 35 (36.1%) <0.0001
Physical findings by research nurse of
Peripheral edemaa 109/336 (32.4%) 34/85 (40.0%) 0.1886
Auscultatory rales 64/328 (19.5%) 26/91 (28.6%) 0.0626
Third heart sound 7/338 (2.1%) 4/89 (4.5%) 0.2516
Jugular venous elevation 2.5±0.8 cm (N=287) 2.6±1.2 cm (N=78) 0.5311
a  Not all residents underwent a complete physical examination by the research nurses due to refusal to do so, limited cooperation, significantly 
limited bed mobility or inability to transfer, resulting in missing data. 
CANADIAN GERIATRICS JOURNAL, VOLUME 16, ISSUE 4, DECEMBER 2013
HECKMAN: DIAGNOSING HEART FAILURE IN NURSING HOMES
152
Our data are consistent with other studies in older 
patients. Our findings that orthopnea and PND are specific 
but not very sensitive are similar to those from several 
community-based epidemiologic studies in the U.S. and 
Europe.(39-42) A systematic review of studies of the utility 
of signs and symptoms for detecting HF in primary care 
showed sensitivities of 29–47% and 44%, and specificities 
of 73–98% and 89%, for PND and orthopnea, respectively.
(39) In contrast, our study found lower specificities for 
histories of peripheral edema and dyspnea, likely reflect-
ing the non-specific presentation of HF in LTC residents. 
Physical findings of HF were infrequent in this sample 
and unhelpful for confirming a prior HF diagnosis, pos-
sibly reflecting the relative clinical stability of new LTC 
residents. These results do not negate the importance of 
these physical examination maneuvers when assessing 
acutely unwell residents.(43,44)
Cardiovascular co-morbidities were common in the 
entire sample. Not surprisingly, CAD and hypertension were 
relatively sensitive for a prior HF diagnosis,(18) though only 
CAD was included in the final model. Admission HF medica-
tions had poor to modest sensitivity for prior HF, consistent 
with their underuse in older patients.(45) The absence of HF 
medications from the admission drug profile makes a prior 
HF diagnosis less likely.
Our study has a number of strengths and limitations. 
Data were collected prospectively, and we obtained substan-
tial clinical information from multiple sources to facilitate 
the confirmation of a prior HF diagnosis by two independent 
reviewers. This information is not readily available in usual 
practice. Though our procedures may have missed a small 
proportion of residents with mild HF who might never have 
been hospitalized, it is likely that the majority of those with 
prior HF were identified. The prevalence of HF in our sample 
TABLE 3.
Properties of individual elements of the admission clinical assessment to predict the diagnosis of HF
Element From the Chart From Resident History Chart or Resident History
Sn Sp Sn Sp Sn Sp PPV NPV c-statistic
Admission assessment history of:
HF 0.856 0.875 0.412 0.903 0.876 0.821 0.574 0.960 0.849
Fluid on the lungs 0.268 0.986  0.381 0.901 0.505 0.895 0.570 0.868 0.700
Peripheral edema 0.443 0.761 0.794 0.443 0.845 0.406 0.282 0.905 0.626
Orthopnea 0.175 0.977 0.381 0.827 0.454 0.821 0.411 0.845 0.637
PND 0.134 0.991 0.258 0.906 0.309 0.903 0.469 0.826 0.606
Dyspnea on moderate activity 0.021 0.974 0.608 0.664 0.608 0.650 0.324 0.857 0.629
Dyspnea compared to peers 0.010 0.989 0.381 0.855 0.381 0.846 0.407 0.832 0.614
Dyspnea walking on the level 0.278 0.926 0.526 0.766 0.608 0.741 0.393 0.872 0.674
Dyspnea with ADLs 0.237 0.937 0.402 0.889 0.505 0.840 0.467 0.860 0.673
Dyspnea at rest 0.216 0.957 0.227 0.915 0.361 0.897 0.493 0.836 0.629
Cardiovascular comorbidities:
Coronary Artery Disease
Atrial Fibrillation
Hypertension
Diabetes mellitus
0.763
0.546
0.722
0.278
0.644
0.795
0.347
0.770
0.660
0.216
0.670
0.237
0.735
0.915
0.446
0.773
0.814
0.567
0.856
0.289
0.595
0.770
0.284
0.753
0.357
0.404
0.248
0.243
0.921
0.866
0.877
0.793
0.705
0.668
0.570
0.521
Physical findings by research nurse of:a
Rales on auscultation N/A N/A N/A N/A 0.286 0.805 0.289 0.802 0.545
Peripheral edema
Third heart sound
Jugular venous elevation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
0.400
0.876
0.051
0.676
0.040
0.983
0.238
0.204
0.444
0.817
0.636
0.792
0.538
0.511
0.517
Admission HF medications:
Furosemide N/A N/A N/A N/A 0.660 0.764 0.435 0.891 0.712
ACE inhibitor N/A N/A N/A N/A 0.464 0.688 0.290 0.823 0.576
β-Blocker N/A N/A N/A N/A 0.474 0.776 0.368 0.843 0.625
Digoxin N/A N/A N/A N/A 0.247 0.932 0.500 0.818 0.590
a  Not all residents underwent a complete physical examination by the research nurses due to refusal to do so, limited cooperation, significantly 
limited bed mobility or inability to transfer.
hf = heart failure; pnd = paroxysmal nocturnal dyspnea; sn = sensitivity; sp = specificity; ppv = positive predictive value; npv = negative pre-
dictive value; adls = activities of daily living; acei = angiotensin converting enzyme inhibitor; n/a = not applicable 
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is consistent with that of a recent systematic review.(5) We re-
lied on residents/caregivers to accurately recall their medical 
history, and LTC staff to identify and accurately document 
symptoms and signs among residents for whom they cared, 
limitations that reflect the clinical conditions under which 
Canadian LTC clinicians operate. Since the completion of 
this study, the indications for aldosterone antagonists in the 
care of HF with reduced ejection fraction have expanded.(18) 
While it is possible that this has translated into greater usage 
of this class of medications in the LTC setting, it is not clear 
whether this would improve upon the diagnostic accuracy 
of HF in LTC, given the limited utility of other HF medica-
tions in this regard. Finally, the average accrual rate for this 
study was lower than expected.(46) Recruitment required that 
potential participants be first contacted by LTC staff within 
six weeks of admission, a period of turmoil during which 
clinical and administrative priorities take precedent over 
research studies. Recruitment difficulties were compounded 
by frequent turnover of LTC staff. Finally, nine LTC homes 
underwent significant expansion and were unable to partici-
pate in our study, but also diverted all new admissions from 
other participating homes for extended periods. Despite these 
concerns, clinical characteristics of residents enrolled in this 
study are similar to those from other studies,(7,9) providing 
reassurance as to the representativeness of the sample.
CONCLUSION
In summary, HF is prevalent LTC. Correctly diagnosing HF is 
crucial to ensure that affected residents receive optimal man-
agement. Our data suggest that the most useful indicator of a 
prior HF diagnosis in new LTC residents include histories of 
HF, fluid on the lungs, orthopnea, CAD, and use of loop diuret-
ics and β-blockers. The transfer of health information during 
TABLE 4.
Results of the multivariate analysis to predict the diagnosis of HF based on admission clinical characteristics,  
cardiovascular co-morbidities, and medication profile
Clinical Characteristic Full Model Reduced Model
AOR (95% CI) p value AOR (95% CI) p value c-statistic IDI p value
Admission assessment history of:
HF 11.65 (4.55, 29.83) 13.66 (6.61, 28.24) <0.0001 0.910 0.02 0.0682
Fluid on the lungs 1.96 (0.83, 4.65) 0.1254 2.01 (1.04, 3.89) 0.0373
Peripheral edema 0.87 (0.30, 2.57) 0.8042
Orthopnea 1.72 (0.69, 4.27) 0.2443 1.76 (0.93,3.33) 0.0834
PND 1.03 (0.36, 2.92) 0.9599
Dyspnea on moderate  activity 0.62 (0.21, 1.84) 0.3920
Dyspnea compared to peers 0.26 (0.07, 0.90) 0.0337
Dyspnea walking on the level 3.17 (1.01, 9.90) 0.0475
Dyspnea with ADLs 3.15 (1.07, 9.31) 0.0377
Dyspnea at rest 0.72 (0.26, 2.02) 0.5336
Cardiovascular comorbidities:
Coronary Artery Disease
Atrial Fibrillation
Hypertension
Diabetes mellitus
2.83 (1.12, 7.15)
1.20 (0.50, 2.91)
0.85 (0.27, 2.66)
0.83 (0.33, 2.09)
0.0282
0.6809
0.7752
0.6979
2.83 (1.42, 5.64) 0.0216
Physical findings:a
Rales on auscultation 0.88 ( 0.46, 1.69) 0.6988
Peripheral edema
Third heart sounds
Jugular venous elevation
1.00 ( 0.54, 1.85)
1.19 (0.20, 7.01)
0.76 (0.08, 7.31)
0.9989
0.8445
0.8116
Admission HF medications:
Furosmide
ACE inhibitor
β-blocker
Digoxin
3.70 (1.52, 9.02)
1.20 (0.54, 2.64)
2.60 (1.15, 5.85)
1.41 (0.43, 4.59)
0.0040
0.6575
0.0216
0.5716
2.11 (1.12, 3.98)
2.09 (1.10, 3.94)
0.0216
0.0234
a  Not all residents underwent a complete physical examination by the research nurses due to refusal to do so, limited cooperation, significantly 
limited bed mobility or inability to transfer.
aor = adjusted odds ratio; ci = confidence interval; hf = heart failure; pnd = paroxysmal nocturnal dyspnea; adls = activities of daily living; 
idi = integrated discrimination improvement index
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the transition to LTC is problematic, and clinicians must rely 
on limited information upon which to formulate a diagnosis of 
HF. Our findings reinforce the importance of a thorough his-
tory, including collateral information from family caregivers, 
when assessing frail seniors upon admission to LTC. 
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